共 50 条
- [31] Eptinezumab for Migraine Prevention in Patients with 2-4 Prior Treatment Failures: DELIVER Subpopulation Analysis JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
- [35] Eptinezumab Improved Work Productivity in Adults With Migraine and Prior Preventive Treatment Failures: Results From the Randomized, Double-Blind, Placebo-Controlled DELIVER Study JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
- [39] Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial The Journal of Headache and Pain, 24
- [40] Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):